7.88 0.08 (1.03%) | 04-19 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 10.53 | 1-year : | 11.5 |
Resists | First : | 9.02 | Second : | 9.85 |
Pivot price | 8.38 | |||
Supports | First : | 7.67 | Second : | 6.38 |
MAs | MA(5) : | 7.98 | MA(20) : | 8.59 |
MA(100) : | 8.38 | MA(250) : | 8.42 | |
MACD | MACD : | -0.4 | Signal : | -0.3 |
%K %D | K(14,3) : | 5.9 | D(3) : | 7.4 |
RSI | RSI(14): 34.6 | |||
52-week | High : | 12.01 | Low : | 5.9 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ VMD ] has closed above bottom band by 21.6%. Bollinger Bands are 40.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 8 - 8.05 | 8.05 - 8.09 |
Low: | 7.62 - 7.68 | 7.68 - 7.73 |
Close: | 7.8 - 7.88 | 7.88 - 7.96 |
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Fri, 19 Apr 2024
Viemed Healthcare (CVE:VMD) Stock Price Down 2% - Defense World
Wed, 17 Apr 2024
Viemed Healthcare: Long-Term Bull Remains Intact But Patience Required (NASDAQ:VMD) - Seeking Alpha
Sun, 14 Apr 2024
Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Sold by Triasima Portfolio Management inc. - MarketBeat
Thu, 11 Apr 2024
When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)? - Simply Wall St
Thu, 11 Apr 2024
Short Interest in Viemed Healthcare, Inc. (NASDAQ:VMD) Grows By 100.6% - Defense World
Wed, 10 Apr 2024
Viemed Healthcare (VMD) Shares Cross Below 200 DMA - Nasdaq
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 39 (M) |
Shares Float | 31 (M) |
Held by Insiders | 12.7 (%) |
Held by Institutions | 62.3 (%) |
Shares Short | 406 (K) |
Shares Short P.Month | 178 (K) |
EPS | 0.25 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 2.96 |
Profit Margin | 5.5 % |
Operating Margin | 11 % |
Return on Assets (ttm) | 7.1 % |
Return on Equity (ttm) | 9.7 % |
Qtrly Rev. Growth | 35.2 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 4.72 |
EBITDA (p.s.) | 0.96 |
Qtrly Earnings Growth | 24.6 % |
Operating Cash Flow | 45 (M) |
Levered Free Cash Flow | 22 (M) |
PE Ratio | 31.52 |
PEG Ratio | 0 |
Price to Book value | 2.66 |
Price to Sales | 1.66 |
Price to Cash Flow | 6.75 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |